| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 17, 2021 | Dec 17, 2021 | C4 Therapeutics, Inc. | Director | Sell | 36.3 | -755 | -6.45% | ✓ | $22.8K |
| Nov 19, 2021 | Nov 19, 2021 | C4 Therapeutics, Inc. | Director | Sell | 36.3 | -755 | -6.06% | ✓ | $30.3K |
| Oct 15, 2021 | Oct 15, 2021 | C4 Therapeutics, Inc. | Director | Sell | 36.3 | -755 | -5.71% | ✓ | $33.9K |
| Sep 17, 2021 | Sep 21, 2021 | C4 Therapeutics, Inc. | Director | Sell | 36.3 | -755 | -5.52% | ✓ | $37.7K |
| Aug 20, 2021 | Aug 24, 2021 | C4 Therapeutics, Inc. | Director | Sell | 36.3 | -755 | -5.23% | ✓ | $30.8K |
| Jul 16, 2021 | Jul 19, 2021 | C4 Therapeutics, Inc. | Director | Sell | 41.3 | -755 | -4.97% | ✓ | $28.2K |
| Jun 18, 2021 | Jun 21, 2021 | C4 Therapeutics, Inc. | Director | Sell | 41.3 | -755 | -4.84% | ✓ | $28.1K |
| May 21, 2021 | May 24, 2021 | C4 Therapeutics, Inc. | Director | Sell | 41.3 | -755 | -4.62% | ✓ | $28K |
| Oct 6, 2020 | Oct 6, 2020 | C4 Therapeutics, Inc. | Director | Buy | 86.3 | +1,315 | 8.96% | ✗ | $25K |